Vulnerability · Published Jan 17, 2025 · Assigned by Roche

CVE-2024-13026Inadequate Encryption Strength Vulnerability in Roche Algo Edge

Medium 6.1

In plain English

A medium-severity security flaw in Algorithm Suite from Roche Diagnostics. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.1% (higher than 3% of all known vulnerabilities).

Severity (CVSS 4.0)6.1Medium

Exploit odds (30 days)0.1%top 97.2% of all CVEs

Exploited in the wildNo reportsCISA SSVC: none

Attack toolingNoneno public tooling known

Official description

A vulnerability exists in Algo Edge up to 2.1.1 - a previously used (legacy) component of navify® Algorithm Suite. The vulnerability impacts the authentication mechanism of this component and could allow an attacker with adjacent access to the laboratory network and the Algo Edge system to craft valid authentication tokens and access the component. Other components of navify® Algorithm Suite are not affected.

Affected products (as reported)

Vendor	Product	Versions
Roche Diagnostics	Algorithm Suite	0 – before 2.1.2

Weakness: CWE-326 · Vector: CVSS:4.0/AV:A/AC:H/AT:P/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/S:N/AU:N/R:A/V:D/RE:L/U:Clear

References

https://diagnostics.roche.com/content/dam/diagnostics/Blueprint/en/pdf/Algo%20Edge%20-%20Authentication%20Vulnerability%20-%20Product%20Security%20Advisory.pdf vendor-advisory